FDA Approves Tecentriq® as First Immunotherapy Regimen for Breast Cancer
A breakthrough therapy is offering unprecedented hope to women with metastatic triple negative breast.... Read More
It's a long way from rural Iowa to Nashville, but Meredith McKean, MD, MPH, has navigated it well, with a few stops in between. In June, McKean was named among the newest rese.... Read More
Lung cancer is no longer an automatic death sentence thanks in part to work being done in Nashville, including studies at Sarah Cannon Research Institute, the research arm of.... Read More
Johanna C. Bendell, MD Medical Oncologist Tennessee Oncology PLLC Director, GI Cancer Research Program & Associate Director, Drug Development Program Sarah Cannon Research.... Read More
It's a diagnosis everyone fears, but Tennessee Oncology and Sarah Cannon physician-scientist Erika P. Hamilton, MD said advances in clinical care and research are helping turn.... Read More